Revolutionizing pneumococcal vaccination: Modular DNA nanoclusters for multivalent protection without carrier suppression

• Forschungsstelle: INNOSUISSE
• Projektnummer: 135.257 IP-LS
• Projekttitel Englisch: Revolutionizing pneumococcal vaccination: Modular DNA nanoclusters for multivalent protection without carrier suppression

Schlüsselwörter (Englisch)

Life sciences, Biotechnology and processing

Abstract (Englisch)

This project will provide the first proof of concept that DNA nanoclusters can serve as a modular, multivalent pneumococcal conjugate vaccine platform, overcoming carrier suppression and enhancing immune-cell engagement for stronger and longer-lasting immunity.